In a case report of a nivolumab-related hypothyroidism, the anti-PD-L1 therapy suppressed the inhibitory PD-1/PD-L1 signals on follicular helper T cells (Th), leading to increased proliferation and subsequent overproduction of thyroid autoantibodies [16]. The gene discussed is PDCD1; the disease is hypothyroidism.